Analyst Ratings for Seelos Therapeutics (SEEL)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/21/2023 | Guggenheim | Yatin Suneja | Downgrade | Neutral (Buy) |
N/A (N/A) |
0.31 (1.28) |
312.9% | Details |
| 9/21/2023 | Cantor Fitzgerald | Charles C. Duncan | Downgrade | Neutral (Overweight) |
N/A (N/A) |
1.00 (1.28) |
28% | Details |
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||


